Pediatric and Adolescent Nephrology Facing the Future: Diagnostic Advances and Prognostic Biomarkers in Everyday Practice
The Special Issue entitled “Pediatric and adolescent nephrology facing the future: diagnostic advances and prognostic biomarkers in everyday practice” contains articles written in the era when COVID-19 had not yet been a major clinical problem in children. Now that we know its multifaceted clinical...
Saved in:
| HerausgeberIn: | |
|---|---|
| Sonstige: | |
| Year of Publication: | 2022 |
| Language: | English |
| Physical Description: | 1 electronic resource (304 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 04904nam-a2201417z--4500 | ||
|---|---|---|---|
| 001 | 993576080904498 | ||
| 005 | 20231214133622.0 | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 202301s2022 xx |||||o ||| 0|eng d | ||
| 020 | |a 3-0365-5974-4 | ||
| 035 | |a (CKB)5470000001633455 | ||
| 035 | |a (oapen)https://directory.doabooks.org/handle/20.500.12854/95834 | ||
| 035 | |a (EXLCZ)995470000001633455 | ||
| 041 | 0 | |a eng | |
| 100 | 1 | |a Taranta-Janusz, Katarzyna |4 edt | |
| 245 | 1 | 0 | |a Pediatric and Adolescent Nephrology Facing the Future: Diagnostic Advances and Prognostic Biomarkers in Everyday Practice |
| 246 | |a Pediatric and Adolescent Nephrology Facing the Future | ||
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
| 300 | |a 1 electronic resource (304 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 520 | |a The Special Issue entitled “Pediatric and adolescent nephrology facing the future: diagnostic advances and prognostic biomarkers in everyday practice” contains articles written in the era when COVID-19 had not yet been a major clinical problem in children. Now that we know its multifaceted clinical course, complications concerning the kidneys, and childhood-specific post-COVID pediatric inflammatory multisystem syndrome (PIMS), the value of diagnostic and prognostic biomarkers in the pediatric area should be appreciated, and their importance ought to increase. | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 650 | 7 | |a Clinical & internal medicine |2 bicssc | |
| 653 | |a chronic kidney disease | ||
| 653 | |a cytokines | ||
| 653 | |a solitary functioning kidney | ||
| 653 | |a tumor necrosis factor-like weak inducer of apoptosis | ||
| 653 | |a netrin-1 | ||
| 653 | |a renal tubular damage | ||
| 653 | |a premature newborns | ||
| 653 | |a overactive bladder | ||
| 653 | |a urinary microbiome | ||
| 653 | |a children | ||
| 653 | |a adolescents | ||
| 653 | |a cystatin C | ||
| 653 | |a galectin-3 | ||
| 653 | |a periostin | ||
| 653 | |a primary hypertension | ||
| 653 | |a arterial damage | ||
| 653 | |a blood pressure | ||
| 653 | |a neurogenic bladder | ||
| 653 | |a myelomeningocele | ||
| 653 | |a markers | ||
| 653 | |a furosemide stress test | ||
| 653 | |a hyperfiltration | ||
| 653 | |a [IGFBP-7] × [TIMP-2] | ||
| 653 | |a NGAL | ||
| 653 | |a renal angina index | ||
| 653 | |a renal functional reserve | ||
| 653 | |a tubular damage | ||
| 653 | |a tubuloglomerular feedback | ||
| 653 | |a neurotrophins | ||
| 653 | |a transcutaneous electrical nerve stimulation | ||
| 653 | |a hemopexin | ||
| 653 | |a nephrotic syndrome | ||
| 653 | |a HNF1B | ||
| 653 | |a hyperuricemia | ||
| 653 | |a PTH | ||
| 653 | |a renal function | ||
| 653 | |a uric acid | ||
| 653 | |a FEUA | ||
| 653 | |a sclerostin | ||
| 653 | |a obesity | ||
| 653 | |a childhood | ||
| 653 | |a dental caries | ||
| 653 | |a gingivitis | ||
| 653 | |a kidney injury | ||
| 653 | |a glomerulopathy | ||
| 653 | |a glomerular injury | ||
| 653 | |a alpha-1 acid glycoprotein | ||
| 653 | |a urinary mRNA expression of podocyte-associated proteins | ||
| 653 | |a cathepsin B | ||
| 653 | |a premature neonates | ||
| 653 | |a immaturity | ||
| 653 | |a NT-proBNP | ||
| 653 | |a cardiovascular disease | ||
| 653 | |a common carotid artery intima-media thickness | ||
| 653 | |a bone morphogenetic protein (BMP)-2 | ||
| 653 | |a bone morphogenetic protein (BMP)-6 | ||
| 653 | |a extracellular matrix metalloproteinases inducer (EMMPRIN) | ||
| 653 | |a macrophage migration inhibitory factor (MIF) | ||
| 653 | |a tubular functional reserve | ||
| 653 | |a cytokeratin-18 | ||
| 653 | |a endoglin | ||
| 653 | |a transforming growth factor-β1 | ||
| 653 | |a renal fibrosis | ||
| 653 | |a congenital obstructive nephropathy | ||
| 653 | |a diabetic kidney disease | ||
| 653 | |a vascular endothelial markers | ||
| 653 | |a eGFR | ||
| 653 | |a adenine nucleotide metabolites | ||
| 653 | |a chronic renal failure | ||
| 653 | |a antibiotic resistance | ||
| 653 | |a Escherichia coli | ||
| 653 | |a inflammatory markers | ||
| 653 | |a urinary tract infection | ||
| 653 | |a B2M | ||
| 653 | |a cancer | ||
| 653 | |a CCS | ||
| 653 | |a CKD | ||
| 653 | |a nephropathies | ||
| 653 | |a renal toxicity | ||
| 653 | |a voiding cystography | ||
| 653 | |a infection | ||
| 653 | |a urinary tract | ||
| 653 | |a IgA nephropathy | ||
| 653 | |a IgA vasculitis with nephritis | ||
| 653 | |a vanin-1 | ||
| 653 | |a biomarker | ||
| 653 | |a urinary tract infections | ||
| 653 | |a artificial intelligence | ||
| 653 | |a machine learning | ||
| 653 | |a medical decision support system | ||
| 776 | |z 3-0365-5973-6 | ||
| 700 | 1 | |a Musiał, Kinga |4 edt | |
| 700 | 1 | |a Taranta-Janusz, Katarzyna |4 oth | |
| 700 | 1 | |a Musiał, Kinga |4 oth | |
| 906 | |a BOOK | ||
| ADM | |b 2023-12-15 05:59:28 Europe/Vienna |f system |c marc21 |a 2023-01-18 06:03:23 Europe/Vienna |g false | ||
| AVE | |i DOAB Directory of Open Access Books |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5342443420004498&Force_direct=true |Z 5342443420004498 |b Available |8 5342443420004498 | ||